Injective (INJ), a decentralized first-layer blockchain, reached a peak of $26, marking a significant increase in recent weeks. The main reason for this surge was the Injective 3.0 update, approved by 99.99% of community members. The new version introduces deflationary mechanisms aimed at reducing the total supply of tokens, which developers believe should increase their value and attractiveness to investors.
Injective 3.0 implements enhanced features for DeFi applications, simplifies integration with Web3, and offers a broader set of tools for developers. The update makes the platform more competitive, expanding opportunities for users and projects built on INJ.
Since its launch, the project has been supported by major venture investors, including Binance Labs and Pantera Capital. This enhances trust in the platform and stimulates growing interest in the token.
However, experts remind us of the high volatility of the cryptocurrency market, emphasizing the importance of a measured approach when investing in INJ and similar tokens.